CRIS Current Research Information System

CAPELLARI, SABINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.491
AS - Asia 12.135
EU - Europa 10.186
SA - Sud America 777
AF - Africa 648
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 4
Totale 37.273
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.300
SG - Singapore 3.348
VN - Vietnam 3.146
CN - Cina 2.965
GB - Regno Unito 2.299
IT - Italia 2.172
DE - Germania 1.625
HK - Hong Kong 930
SE - Svezia 744
NL - Olanda 700
FR - Francia 603
BR - Brasile 565
IN - India 550
RU - Federazione Russa 456
UA - Ucraina 385
IE - Irlanda 341
KR - Corea 294
FI - Finlandia 215
JP - Giappone 204
CI - Costa d'Avorio 177
ZA - Sudafrica 171
SC - Seychelles 138
EE - Estonia 132
AT - Austria 103
CA - Canada 103
ID - Indonesia 96
JO - Giordania 90
PH - Filippine 83
TG - Togo 81
AR - Argentina 76
BG - Bulgaria 67
MX - Messico 67
BD - Bangladesh 66
CH - Svizzera 54
TH - Thailandia 53
BE - Belgio 51
ES - Italia 49
IQ - Iraq 49
PL - Polonia 43
TR - Turchia 40
UZ - Uzbekistan 34
TW - Taiwan 32
CO - Colombia 31
EC - Ecuador 30
GR - Grecia 29
AU - Australia 28
SA - Arabia Saudita 26
DK - Danimarca 21
PK - Pakistan 19
VE - Venezuela 19
LT - Lituania 16
MY - Malesia 16
PY - Paraguay 16
RO - Romania 16
HR - Croazia 14
IR - Iran 14
NG - Nigeria 14
PE - Perù 14
CL - Cile 13
TN - Tunisia 12
IL - Israele 11
LB - Libano 11
MA - Marocco 11
CZ - Repubblica Ceca 9
AE - Emirati Arabi Uniti 8
EG - Egitto 7
HU - Ungheria 7
KE - Kenya 6
NO - Norvegia 6
SY - Repubblica araba siriana 6
AL - Albania 5
DZ - Algeria 5
OM - Oman 5
PS - Palestinian Territory 5
PT - Portogallo 5
SN - Senegal 5
UY - Uruguay 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
JM - Giamaica 4
KZ - Kazakistan 4
SR - Suriname 4
AO - Angola 3
GE - Georgia 3
HN - Honduras 3
KH - Cambogia 3
LV - Lettonia 3
LY - Libia 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BZ - Belize 2
CR - Costa Rica 2
GA - Gabon 2
Totale 37.228
Salva come PNG Salva come JPEG
Città #
Singapore 2.320
Southend 1.983
Ashburn 1.408
Fairfield 1.187
Houston 1.008
Chandler 935
Hong Kong 874
Dong Ket 630
Ho Chi Minh City 602
Hefei 599
Ann Arbor 594
Woodbridge 588
Seattle 575
San Jose 551
Wilmington 526
Hanoi 513
Bologna 498
Cambridge 450
Frankfurt am Main 422
Princeton 409
Beijing 355
Santa Clara 350
Dublin 341
Eygelshoven 338
Boardman 274
Dallas 263
Seoul 254
Lauterbourg 237
Jacksonville 225
Los Angeles 201
Tokyo 182
Abidjan 177
Nanjing 166
Westminster 161
Helsinki 151
Council Bluffs 148
Redmond 148
Turin 136
Berlin 128
Padova 127
Munich 122
Milan 121
New York 120
Buffalo 99
Redondo Beach 96
Florence 91
Da Nang 90
Amman 89
Lomé 81
Jinan 80
Shenyang 79
Haiphong 75
Saint Petersburg 74
San Diego 74
Bengaluru 69
São Paulo 67
Sofia 64
Vienna 63
Guangzhou 61
Changsha 60
Shanghai 60
Tianjin 58
Hebei 55
Medford 54
Nuremberg 54
Nanchang 51
Des Moines 50
Jakarta 50
London 50
Brussels 49
Lappeenranta 49
Mülheim 44
Chicago 43
Rome 40
Olalla 39
Amsterdam 37
Montreal 36
Verona 32
Yubileyny 32
Zhengzhou 32
Can Tho 30
Falls Church 30
Jiaxing 30
Toronto 30
Warsaw 30
Orem 29
Phoenix 29
Dearborn 28
Imola 28
Hangzhou 27
Hải Dương 27
Redwood City 26
Bern 25
Haikou 25
Mexico City 25
Mahé 24
Norwalk 24
San Francisco 24
Boydton 23
Bremen 23
Totale 24.161
Salva come PNG Salva come JPEG
Nome #
A new potential biomarker for dementia with Lewy bodies 910
Characterization of the F198S prion protein mutation: enhanced glycosylation and defective refolding 572
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. 514
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 354
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 343
Skin biopsy and microneurography disclose selective noradrenergic dysfunction due to dopamine-β-hydroxylase deficiency 313
Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus? 291
A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project 290
Messenger RNA processing is altered in autosomal dominant leukodystrophy 278
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias 271
Cognitive rehabilitation and transcranial direct current stimulation in a patient with posterior cortical atrophy: An fMRI study 262
Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1 H-MRS and volumetric changes: A two- year retrospective follow-up study 262
Mice overexpressing lamin B1 in oligodendrocytes recapitulate the age-dependent motor signs, but not the early autonomic cardiovascular dysfunction of autosomal-dominant leukodystrophy (ADLD) 250
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 241
Abnormal ADC in the brain of prion disease patients: variation between brain structures. 240
A case of fatal familial insomnia in Africa. 237
Abnormal in vivo cerebral energy metabolism in Huntington’s disease: preliminary findings 233
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 224
Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer's disease and longevity in an Italian population 224
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 222
Benign tremulous parkinsonism in a patient with dardarin mutation. 222
Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions 222
Binary transformation of sequencing data to explore functional genetic patterns. 222
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis 221
A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study 220
Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodystrophy 219
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 219
Color choice preference in cognitively impaired patients: A look inside alzheimer’s disease through the use of lüscher color diagnostic 217
The RET51/FKBP52 complex and its involvement in Parkinson disease. 215
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden 213
Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? 211
A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings 208
A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. 207
Muscle ceroid lipofuscin-like deposits in a patient with corticobasal syndrome due to a progranulin mutation 207
Behçet disease presenting with movement disorders and antibasal ganglia antibodies 206
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 205
Age at onset in genetic prion disease and the design of preventive clinical trials 205
Alterazione del metabolismo energetico cerebrale in vivo nella malattia di Huntington: dati preliminari 204
Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by theCYP4X1gene 203
Human figure drawing distinguishes Alzheimer’s patients: a cognitive screening test study 199
Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants 198
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 198
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients 198
Discrepancies in reporting the CAG repeat lengths for Huntington's disease. 197
Lack of association between five serotonin metabolism-related genes and medication overuse headache 195
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 194
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 193
ADC and Proton Spectroscopy Reflect Cellular Pathology in Patients with Creutzfeldt-Jakob Disease 193
"Agrypnia excitata'' in a case of sporadic Creutzfeldt-Jakob disease VV2 192
Arylsulphatase A activity in familial parkinsonism: a pathogenetic role? 192
An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene. 188
Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: A single-center study 186
Quantifying prion disease penetrance using large population control cohorts 185
The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance 185
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 185
Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy. 182
Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease 182
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. 181
Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. 181
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 181
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study 180
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis 179
Multimodal investigation of melanopsin retinal ganglion cells in Alzheimer's disease 177
Strio-pallido-dentate calcinosis: a diagnostic approach in adult patients 177
Sulcal Morphometry Predicts Mild Cognitive Impairment Conversion to Alzheimer’s Disease 175
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 175
An in vivo proton magnetic resonance spectroscopy study of thalamus in prion disease 174
La risonanza magnetica di diffusione differenzia la degenerazione corticobasale dalla paralisi sopranucleare progressiva e dalla malattia di Parkinson. 172
Reduced in Vivo thalamic N-Acetyl-Aspartate is a Diagnostic Marker of Prion Disease 171
Analyses of Protease Resistance and Aggregation State of Abnormal Prion Protein across the Spectrum of Human Prions 171
Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. 171
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies 171
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 171
Distribution of Diffusivity Changes in Subcortical Deep Gray Matter in Prion Diseases 170
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias 170
Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease 167
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia 167
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 167
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients 164
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification. 163
PROTEIN AMYLOIDOSIS ASSOCIATED WITH A NOVEL STOP CODON MUTATION IN PRNP 162
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 162
Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study 162
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 162
History and state of the art of PrP-res “typing” in Creutzfeldt-Jakob disease 161
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 161
Neurosyphilis orofacial dyskinesia: the candy sign. 161
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 161
A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia 160
The Degree of Cardiovascular Autonomic Dysfunction is not Different in GBA-Related and Idiopathic Parkinson's Disease Patients: A Case-Control Instrumental Evaluation 159
Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. 159
Risk of SARS-CoV-2 infection, hospitalization, and death for COVID-19 in people with Parkinson disease or parkinsonism over a 15-month period: A cohort study 158
Heterogeneity of truncated fragments distinct from PrP27-30 correlates with clinico-pathological subtypes of Creutzfeldt-Jakob disease 157
Nuclear lamins: Functions and clinical implications 157
Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease 157
Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. 157
Observing movement disorders: best practice proposal in the use of video recording in clinical practice 157
Metabolite and lipoprotein profiles reveal sex-related oxidative stress imbalance in de novo drug-naive Parkinson's disease patients 156
Use of in vivo proton magnetic resonance spectroscopy in the differential diagnosis of prion diseases 155
Rapidly Progressive Alzheimer’s Disease: Contributions to Clinical-Pathological Definition and Diagnosis 155
Totale 21.173
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.663
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.529 0 0 0 0 0 0 0 0 0 202 136 1.191
2021/20224.007 386 138 246 212 350 187 87 418 186 382 797 618
2022/20234.230 444 549 192 544 313 298 155 279 708 110 403 235
2023/20241.268 84 182 107 137 109 172 79 110 43 107 75 63
2024/20255.185 239 750 411 362 671 280 468 186 158 452 225 983
2025/202612.824 969 1.328 1.329 1.050 1.451 1.059 1.806 450 2.398 984 0 0
Totale 37.997